THE EMMES COMPANY, LLC - OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

PIID: 75N95024F00007Solicitation ID: 75N95024F00007

Signed Date: Aug 14, 2024Effective Date: Aug 15, 2024End Date: Closes in 566 days

Award $

$1.9M

Vendor

THE EMMES COMPANY, LLC

NAICS

541715

Signed Date

Aug 14, 2024

Key Details

Dollars Obligated

$1.9M

Base & All Options

$1.9M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Parent IDIQ (PIID)

75N95022D00017

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

ROCKVILLE, MD

Description

OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

Context & Analysis

On Aug 14, 2024, Department of Health and Human Services obligated $1,860,579 to THE EMMES COMPANY, LLC for optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (ctn-0100). august 15, 2024 to march 31, 2028. n01da-22-2253. task order no. 75n95024f00007 (to23)…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in ROCKVILLE, MD. The contract is scheduled through Mar 31, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.